Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept … DE Kandzari, M Böhm, F Mahfoud, RR Townsend, MA Weber, S Pocock, ... The Lancet 391 (10137), 2346-2355, 2018 | 829 | 2018 |
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled … RR Townsend, F Mahfoud, DE Kandzari, K Kario, S Pocock, MA Weber, ... The Lancet 390 (10108), 2160-2170, 2017 | 802 | 2017 |
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial M Böhm, K Kario, DE Kandzari, F Mahfoud, MA Weber, RE Schmieder, ... The Lancet 395 (10234), 1444-1451, 2020 | 508 | 2020 |
National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: guidelines for the prevention, detection, and management of heart failure in Australia 2018 JJ Atherton, A Sindone, CG De Pasquale, A Driscoll, PS MacDonald, ... Heart, Lung and Circulation 27 (10), 1123-1208, 2018 | 409 | 2018 |
Breast implant–associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk A Loch-Wilkinson, KJ Beath, RJW Knight, WLF Wessels, M Magnusson, ... Plastic and reconstructive surgery 140 (4), 645-654, 2017 | 398 | 2017 |
Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials I Hopper, B Billah, M Skiba, H Krum European Journal of Cardiovascular Prevention & Rehabilitation 18 (6), 813-823, 2011 | 208 | 2011 |
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial F Mahfoud, DE Kandzari, K Kario, RR Townsend, MA Weber, ... The Lancet 399 (10333), 1401-1410, 2022 | 178 | 2022 |
Dipeptidyl peptidase‐4 inhibitors and cardiovascular outcomes: meta‐analysis of randomized clinical trials with 55,141 participants S Wu, I Hopper, M Skiba, H Krum Cardiovascular therapeutics 32 (4), 147-158, 2014 | 176 | 2014 |
Worsening renal function during renin–angiotensin–aldosterone system inhibitor initiation and long‐term outcomes in patients with left ventricular systolic dysfunction H Clark, H Krum, I Hopper European journal of heart failure 16 (1), 41-48, 2014 | 158 | 2014 |
Physicians' guideline adherence is associated with long‐term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international … M Komajda, J Schöpe, S Wagenpfeil, L Tavazzi, M Böhm, P Ponikowski, ... European Journal of Heart Failure 21 (7), 921-929, 2019 | 126 | 2019 |
Effectiveness of Curcuma longa Extract for the Treatment of Symptoms and Effusion–Synovitis of Knee Osteoarthritis: A Randomized Trial Z Wang, G Jones, T Winzenberg, G Cai, LL Laslett, D Aitken, I Hopper, ... Annals of internal medicine 173 (11), 861-869, 2020 | 106 | 2020 |
Complementary therapies and the medical profession: a study of medical students' attitudes. I Hopper, M Cohen Alternative Therapies in Health and Medicine 4 (3), 68-73, 1998 | 99 | 1998 |
Withdrawal of antihypertensive drugs in older people E Reeve, V Jordan, W Thompson, M Sawan, A Todd, TM Gammie, ... Cochrane Database of Systematic Reviews, 2020 | 94 | 2020 |
Medical therapies for heart failure with preserved ejection fraction SE Kjeldsen, TG von Lueder, OA Smiseth, K Wachtell, N Mistry, ... Hypertension 75 (1), 23-32, 2020 | 92 | 2020 |
Observational studies and their utility for practice JFM Gilmartin-Thomas, D Liew, I Hopper Australian prescriber 41 (3), 82, 2018 | 86 | 2018 |
Impact of heart failure and changes to volume status on liver stiffness: non‐invasive assessment using transient elastography I Hopper, W Kemp, P Porapakkham, Y Sata, E Condon, M Skiba, L Farber, ... European journal of heart failure 14 (6), 621-627, 2012 | 85 | 2012 |
SPYRAL HTN-OFF MED trial investigators*. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN … RR Townsend, F Mahfoud, DE Kandzari, K Kario, S Pocock, MA Weber, ... Lancet 390 (10108), 2160-2170, 2017 | 81 | 2017 |
Dementia, cognitive impairment and proton pump inhibitor therapy: a systematic review R Batchelor, JFM Gilmartin, W Kemp, I Hopper, D Liew Journal of gastroenterology and hepatology 32 (8), 1426-1435, 2017 | 81 | 2017 |
National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of heart failure 2018 JJ Atherton, A Sindone, CG De Pasquale, A Driscoll, PS MacDonald, ... Medical Journal of Australia 209 (8), 363-369, 2018 | 72 | 2018 |
Systematic review with meta‐analysis: risk of adverse cardiovascular events with proton pump inhibitors independent of clopidogrel R Batchelor, R Kumar, JFM Gilmartin‐Thomas, I Hopper, W Kemp, D Liew Alimentary Pharmacology & Therapeutics 48 (8), 780-796, 2018 | 67 | 2018 |